DEA monitors substance use and public health issues in North Dakota, where Bismarck serves as the capital city.
1 report, 1 independent
Updated Aug 3
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
DEA monitors substance use and public health issues in North Dakota, where Bismarck serves as the capital city.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- The Federal DEA has classified a kratum derivative as a schedule one drug.Sub-event
DEA is monitoring substance use and public health issues in North Dakota.1 source
Keep exploring
The entities involved
-
North Dakota
state of the United States of America
-
Drug Enforcement Administration
United States federal law enforcement agency
Related events
- The North Dakota state government convened in the capital city of Bismarck.
- The DEA is involved in a major opioid lawsuit in Wilmington, Delaware, facing a company, with a judge presiding over the case.
- North Dakota struggles with regulating foreign manufactured products, while the FDA classifies chemically manipulated products as opioids.
- Bismarck serves as the capital city of the state of North Dakota.
- Lawmakers in North Dakota are simultaneously debating kratom substance controls and addressing misinformation regarding federal Medicare spending.